A detailed history of Keudell transactions in Pfizer Inc stock. As of the latest transaction made, Keudell holds 18,769 shares of PFE stock, worth $501,507. This represents 0.15% of its overall portfolio holdings.

Number of Shares
18,769
Previous 18,188 3.19%
Holding current value
$501,507
Previous $508,000 6.89%
% of portfolio
0.15%
Previous 0.15%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$27.7 - $31.39 $16,093 - $18,237
581 Added 3.19%
18,769 $543,000
Q2 2024

Jul 16, 2024

BUY
$25.26 - $29.6 $18,919 - $22,170
749 Added 4.29%
18,188 $508,000
Q1 2024

May 07, 2024

SELL
$25.89 - $29.73 $20,582 - $23,635
-795 Reduced 4.36%
17,439 $483,000
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $213,534 - $277,357
-8,172 Reduced 30.95%
18,234 $524,000
Q3 2023

Oct 18, 2023

SELL
$32.09 - $37.51 $110,517 - $129,184
-3,444 Reduced 11.54%
26,406 $875,000
Q2 2023

Jul 20, 2023

SELL
$36.12 - $41.79 $130,284 - $150,736
-3,607 Reduced 10.78%
29,850 $1.09 Million
Q1 2023

Apr 18, 2023

SELL
$39.39 - $51.28 $23,712 - $30,870
-602 Reduced 1.77%
33,457 $1.37 Million
Q4 2022

Jan 20, 2023

SELL
$41.75 - $54.5 $68,261 - $89,107
-1,635 Reduced 4.58%
34,059 $0
Q3 2022

Oct 12, 2022

BUY
$43.76 - $53.42 $17,810 - $21,741
407 Added 1.15%
35,694 $1.56 Million
Q2 2022

Jul 18, 2022

BUY
$46.53 - $55.17 $72,028 - $85,403
1,548 Added 4.59%
35,287 $1.85 Million
Q1 2022

Apr 18, 2022

SELL
$45.75 - $56.69 $271,297 - $336,171
-5,930 Reduced 14.95%
33,739 $1.75 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $8,883 - $13,168
-215 Reduced 0.54%
39,669 $2.34 Million
Q3 2021

Oct 20, 2021

SELL
$39.25 - $50.42 $102,089 - $131,142
-2,601 Reduced 6.12%
39,884 $1.72 Million
Q2 2021

Jul 13, 2021

BUY
$35.91 - $40.68 $176,425 - $199,860
4,913 Added 13.08%
42,485 $1.66 Million
Q1 2021

Apr 13, 2021

BUY
$33.49 - $37.77 $185,668 - $209,396
5,544 Added 17.31%
37,572 $1.36 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $82,670 - $105,123
2,470 Added 8.36%
32,028 $1.18 Million
Q3 2020

Oct 20, 2020

BUY
$31.75 - $37.25 $72,453 - $85,004
2,282 Added 8.37%
29,558 $1.09 Million
Q2 2020

Jul 14, 2020

BUY
$30.12 - $36.54 $68,161 - $82,690
2,263 Added 9.05%
27,276 $892,000
Q1 2020

Apr 20, 2020

BUY
$27.03 - $38.62 $70,737 - $101,068
2,617 Added 11.69%
25,013 $816,000
Q4 2019

Jan 29, 2020

BUY
$32.92 - $37.36 $162,493 - $184,408
4,936 Added 28.27%
22,396 $877,000
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $12,411 - $16,093
382 Added 2.24%
17,460 $627,000
Q2 2019

Aug 23, 2019

BUY
$36.98 - $41.52 $631,544 - $709,078
17,078 New
17,078 $625,000
Q2 2019

Aug 21, 2019

SELL
$36.98 - $41.52 $375,494 - $421,594
-10,154 Closed
0 $0
Q1 2019

Aug 21, 2019

BUY
$37.5 - $41.2 $380,775 - $418,344
10,154 New
10,154 $431,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Keudell Portfolio

Follow Keudell and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.